Doximity is trading at $27.86, up 5.03%, with no clear company-specific catalyst identified for the September 30, 2026 move.

  • Evercore ISI maintained an In Line rating and lowered its price target to $35 from $40; that analyst action does not explain the rise.
  • Broader-market signals are mixed: the Nasdaq was up 0.62%, while Reuters reported U.S. index futures lower ahead of inflation and GDP data. Available evidence does not establish a cause for Doximity’s gain.